SCHEMBL13910280

SCHEMBL13910280

C/N=C1\OCCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13900999 0.75 — —
SCHEMBL13077982 0.73 — —
SCHEMBL22201958 0.72 ALDH1A1 (0.31) —
SCHEMBL22202016 0.70 — —
SCHEMBL11845472 0.69 GRM5 (0.36) —
SCHEMBL9812155 0.66 MAPT (0.40) —
SCHEMBL12569937 0.65 — —
SCHEMBL8617283 0.63 — —
SCHEMBL149594 0.63 — —
SCHEMBL16498026 0.63 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7501427-B2 Quinazoline analogs as receptor tyrosine kinase inhibitors ARRAY BIOPHARMA, INC. (US) 2009-03-10 — — US disclosed
Send feedback